Argentina to set up radiopharma and bioproducts evaluations centre
This article was originally published in Clinica
Executive Summary
The Argentine health ministry is to establish a radiopharmaceuticals and bioproducts evaluations centre, as part of a programme to modernise national healthcare regulatory agency ANMAT. The initiative was approved last week with the signing of a memorandum of understanding with the World Bank, which is providing US$4.5m. Other plans outlined in a health ministry statement on the programme include: better monitoring, through "fiscalisation measures", of the quality standards of healthcare products; and developing the agency's R&D activities.